Radiolabelling and preclinical characterization of 89 Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa.

MLA

Burvenich, Ingrid Julienne Georgette, et al. “Radiolabelling and Preclinical Characterization of 89 Zr-Df-Radiolabelled Bispecific Anti-PD-L1/TGF-ΒRII Fusion Protein Bintrafusp Alfa.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 10, Sept. 2021, pp. 3075–88. EBSCOhost, https://doi.org/10.1007/s00259-021-05251-0.

APA

Burvenich, I. J. G., Goh, Y. W., Guo, N., Gan, H. K., Rigopoulos, A., Cao, D., Liu, Z., Ackermann, U., Wichmann, C. W., McDonald, A. F., Huynh, N., O’Keefe, G. J., Gong, S. J., Scott, F. E., Li, L., Geng, W., Zutshi, A., Lan, Y., & Scott, A. M. (2021). Radiolabelling and preclinical characterization of 89 Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European Journal of Nuclear Medicine and Molecular Imaging, 48(10), 3075–3088. https://doi.org/10.1007/s00259-021-05251-0

Chicago

Burvenich, Ingrid Julienne Georgette, Yit Wooi Goh, Nancy Guo, Hui Kong Gan, Angela Rigopoulos, Diana Cao, Zhanqi Liu, et al. 2021. “Radiolabelling and Preclinical Characterization of 89 Zr-Df-Radiolabelled Bispecific Anti-PD-L1/TGF-ΒRII Fusion Protein Bintrafusp Alfa.” European Journal of Nuclear Medicine and Molecular Imaging 48 (10): 3075–88. doi:10.1007/s00259-021-05251-0.